Berry blend may buy time after early water break
NCT ID NCT06788132
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a daily capsule of cranberry, hibiscus, vitamin C, and lactobacillus could lengthen the time between a pregnant woman's waters breaking early (between 24 and 34 weeks) and delivery. 84 women were randomly assigned to receive either the supplement or a placebo for 10 days. The goal was to see if the supplement could safely delay birth and reduce complications for both mother and baby.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cranberry extract, hibiscus extract, vitamin C, and lactobacillus
What this could lead to
If it works, this could offer a simple, natural way to delay delivery after waters break early, potentially reducing complications for mother and baby.
What could go wrong
This is a small, completed trial with only 84 participants. The results may not apply to all pregnant women, and supplements may not significantly extend the latency period.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE RUPTURE OF MEMBRANES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Escuela
Tegucigalpa, Francisco Morazán Department, 11101, Honduras